Delivery Order SPE2DB24D8002-SPE2DB25FJNBJ
Award Date
1/29/25
Potential Completion Date
1/30/25
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,024.65 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The award has an ultimate completion date of October 23, 2024 and is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) for a comprehensive range of pharmaceutical products,...
This is a $8,471.66 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The contract has an ultimate completion date of January 24, 2025. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a comprehensive range of...
This is a firm fixed-price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) on December 16, 2024. The contract, valued at $6,671.79, is for the delivery of Eliquis 5 mg tablets with a completion date of December 17, 2024. This award is part of the DLA's Troop Support Medical ECAT Generation V Program, a larger indefinite delivery contract valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a wide...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The contract has a ceiling value of $13,109.49 and a period of performance through August 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V Program, which has a total potential value of $999,999,999.00 and is used to procure...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $8,304.36, is for the delivery of Eliquis 5 mg tablets. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of...
This $6,510.02 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Eliquis 5 mg tablets, a pharmaceutical product, with a completion date of December 6, 2024. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, SPE2DB24D8001, valued at $999,999,999.00. This IDC, part of the DLA Troop Support Medical's...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $11,250.93 and a performance period through January 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC is part of the DLA Troop...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,179.50, is for the delivery of 60 tablets of the pharmaceutical product Eliquis 5 mg. The contract has an ultimate completion date of October 31, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., identified as SPE2DB24D8001, valued at $999,999,999.00....
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Eliquis 5 mg tablet prescriptions, with a ceiling value of $16,738.09 and a performance period through November 19, 2024. The award is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of...
This is a delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) for the delivery of Eliquis 5 mg tablets. The contract, valued at $10,949.56, has a firm fixed price and an ultimate completion date of December 4, 2024. Dakota Drug, Inc. is the prime contractor, and there are no major subcontractors mentioned. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which is an Indefinite...